CLINICAL_TRIALS
trial_result
· 2009-07-31
Clinical Trial Update: Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus [Phase 1]
Summary
Phase 1 multiple-dose escalation trial of PF-04603629 in subjects with Type 2 diabetes mellitus; the study status is terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: TERMINATED